Invasive carcinoma of breast
Item
histologically or cytologically confirmed invasive breast cancer
boolean
C0853879 (UMLS CUI [1])
Complete excision Primary tumor
Item
complete resection of primary tumor
boolean
C0015250 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
Disease TNM Breast tumor staging
Item
stage i-iii (t1-3, n0-3, m0) disease
boolean
C0012634 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
Study Subject Participation Status | Clinical Trial Specified
Item
enrolled in clinical trial can-ncic-ma27.
boolean
C2348568 (UMLS CUI [1])
C0008976 (UMLS CUI [2,1])
C0205369 (UMLS CUI [2,2])
Exclusion Criteria | Breast cancer recurrent Local | Secondary malignant neoplasm of female breast
Item
no locally recurrent or metastatic breast cancer
boolean
C0680251 (UMLS CUI [1])
C0278493 (UMLS CUI [2,1])
C0205276 (UMLS CUI [2,2])
C0346993 (UMLS CUI [3])
Hormone Receptor Status
Item
hormone receptor status:
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
Disease Estrogen receptor positive | Disease Progesterone receptor positive
Item
estrogen receptor- or progesterone receptor-positive disease
boolean
C0012634 (UMLS CUI [1,1])
C0279754 (UMLS CUI [1,2])
C0012634 (UMLS CUI [2,1])
C0279759 (UMLS CUI [2,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Postmenopausal state
Item
postmenopausal status, defined as one of the following:
boolean
C0232970 (UMLS CUI [1])
Age
Item
at least 60 years old
boolean
C0001779 (UMLS CUI [1])
Age | Amenorrhea Spontaneous Duration | Chemotherapy
Item
age 45-59 years with spontaneous cessation of menses for > 12 months prior to chemotherapy or study randomization
boolean
C0001779 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0205359 (UMLS CUI [2,2])
C0449238 (UMLS CUI [2,3])
C0392920 (UMLS CUI [3])
Age | Amenorrhea Duration | Amenorrhea Secondary to Hysterectomy | FSH measurement Postmenopausal state | FSH measurement
Item
age 45-59 years with cessation of menses for < 12 months or secondary to hysterectomy and a follicle-stimulating hormone (fsh) level in the postmenopausal range (or > 34.4 iu/l)
boolean
C0001779 (UMLS CUI [1])
C0002453 (UMLS CUI [2,1])
C0449238 (UMLS CUI [2,2])
C0002453 (UMLS CUI [3,1])
C0175668 (UMLS CUI [3,2])
C0020699 (UMLS CUI [3,3])
C0202022 (UMLS CUI [4,1])
C0232970 (UMLS CUI [4,2])
C0202022 (UMLS CUI [5])
Age | Hormone replacement therapy | Breast Carcinoma Diagnosis | Hormone replacement therapy Discontinued | FSH measurement Postmenopausal state | FSH measurement
Item
age 45-59 years on hormone replacement therapy (hrt) and discontinued hrt at diagnosis of breast cancer and fsh level in the postmenopausal range (or > 34.4 iu/l)
boolean
C0001779 (UMLS CUI [1])
C0282402 (UMLS CUI [2])
C0678222 (UMLS CUI [3,1])
C1704338 (UMLS CUI [3,2])
C0282402 (UMLS CUI [4,1])
C1444662 (UMLS CUI [4,2])
C0202022 (UMLS CUI [5,1])
C0232970 (UMLS CUI [5,2])
C0202022 (UMLS CUI [6])
Bilateral oophorectomy
Item
bilateral oophorectomy
boolean
C0278321 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
ID.16
Item
see disease characteristics
boolean